Requisite Capital Management’s AbbVie ABBV Stock Holding History

Requisite Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$220K	Buy	+876	New	+$188K	0.04%	110
2026 Q1	–	Sell	-876	Closed	-$200K	–	115
2025 Q4	$200K	Sell	876 -127	-13%	-$28.9K	0.04%	118
2025 Q3	$232K	Buy	+1,003	New	+$204K	0.04%	300
2023 Q2	–	Sell	-1,272	Closed	-$203K	–	75
2023 Q1	$203K	Buy	+1,272	New	+$194K	0.06%	59
2022 Q2	–	Sell	-5,215	Closed	-$845K	–	61
2022 Q1	$845K	Buy	5,215 +2,500	+92%	+$363K	0.26%	35
2021 Q4	$368K	Buy	+2,715	New	+$321K	0.11%	54

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Requisite Capital Management's ABBV Position: Q2 2026 in Review

Requisite Capital Management opened a new position in AbbVie (ABBV) in Q2 2026: 876 shares worth $220K. The stake represents 0.04% of the portfolio and ranks #110 among its holdings. This is a return to the name: Requisite Capital Management previously reported a position in ABBV as recently as Q4 2025.

Requisite Capital Management first reported a position in ABBV in Q4 2021 and has held it in 6 quarters since. The position peaked at $845K in Q1 2022. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Requisite Capital Management held 876 shares of AbbVie worth $220K as of Q2 2026.
AbbVie was a new Requisite Capital Management position in Q2 2026.
AbbVie made up 0.04% of Requisite Capital Management's portfolio in Q2 2026, its #110 holding.
Requisite Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 6 quarters since.
Requisite Capital Management's AbbVie position peaked at $845K in Q1 2022.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Requisite Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.